- Home
- CASI vs NXGL Comparison
CASI vs NXGL Comparison
Compare CASI & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- NXGL
- Stock Information
- Founded
- CASI 1991
- NXGL 1997
- Country
- CASI China
- NXGL United States
- Employees
- CASI N/A
- NXGL N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- NXGL Medical/Dental Instruments
- Sector
- CASI Health Care
- NXGL Health Care
- Exchange
- CASI Nasdaq
- NXGL Nasdaq
- Market Cap
- CASI 20.5M
- NXGL 19.7M
- IPO Year
- CASI 1996
- NXGL 2021
- Fundamental
- Price
- CASI $1.29
- NXGL $2.57
- Analyst Decision
- CASI Strong Buy
- NXGL
- Analyst Count
- CASI 1
- NXGL 0
- Target Price
- CASI $4.00
- NXGL N/A
- AVG Volume (30 Days)
- CASI 79.1K
- NXGL 52.9K
- Earning Date
- CASI 08-15-2025
- NXGL 08-13-2025
- Dividend Yield
- CASI N/A
- NXGL N/A
- EPS Growth
- CASI N/A
- NXGL N/A
- EPS
- CASI N/A
- NXGL N/A
- Revenue
- CASI $31,368,000.00
- NXGL $10,228,000.00
- Revenue This Year
- CASI N/A
- NXGL $52.35
- Revenue Next Year
- CASI N/A
- NXGL $42.38
- P/E Ratio
- CASI N/A
- NXGL N/A
- Revenue Growth
- CASI 8.39
- NXGL 116.01
- 52 Week Low
- CASI $1.09
- NXGL $2.10
- 52 Week High
- CASI $7.67
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- CASI 42.66
- NXGL 55.90
- Support Level
- CASI $1.21
- NXGL $2.20
- Resistance Level
- CASI $1.77
- NXGL $2.46
- Average True Range (ATR)
- CASI 0.13
- NXGL 0.20
- MACD
- CASI 0.01
- NXGL -0.01
- Stochastic Oscillator
- CASI 14.29
- NXGL 78.98
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.